nodes	percent_of_prediction	percent_of_DWPC	metapath
Miglustat—GBA2—myometrium—uterine cancer	0.0291	0.0726	CbGeAlD
Miglustat—UGCG—myometrium—uterine cancer	0.0287	0.0716	CbGeAlD
Miglustat—GBA2—uterine cervix—uterine cancer	0.0226	0.0565	CbGeAlD
Miglustat—UGCG—uterine cervix—uterine cancer	0.0223	0.0557	CbGeAlD
Miglustat—GBA2—decidua—uterine cancer	0.0216	0.0538	CbGeAlD
Miglustat—UGCG—decidua—uterine cancer	0.0212	0.0531	CbGeAlD
Miglustat—GBA2—renal system—uterine cancer	0.0212	0.0529	CbGeAlD
Miglustat—UGCG—renal system—uterine cancer	0.0209	0.0521	CbGeAlD
Miglustat—GBA2—endometrium—uterine cancer	0.0205	0.0511	CbGeAlD
Miglustat—UGCG—endometrium—uterine cancer	0.0202	0.0504	CbGeAlD
Miglustat—GBA2—mammalian vulva—uterine cancer	0.0198	0.0494	CbGeAlD
Miglustat—UGCG—mammalian vulva—uterine cancer	0.0195	0.0487	CbGeAlD
Miglustat—UGCG—uterus—uterine cancer	0.0186	0.0464	CbGeAlD
Miglustat—GBA2—female reproductive system—uterine cancer	0.0169	0.0423	CbGeAlD
Miglustat—UGCG—female reproductive system—uterine cancer	0.0167	0.0417	CbGeAlD
Miglustat—GBA2—female gonad—uterine cancer	0.0154	0.0385	CbGeAlD
Miglustat—GBA2—vagina—uterine cancer	0.0153	0.0383	CbGeAlD
Miglustat—UGCG—female gonad—uterine cancer	0.0152	0.038	CbGeAlD
Miglustat—UGCG—vagina—uterine cancer	0.0151	0.0377	CbGeAlD
Miglustat—GBA2—lymph node—uterine cancer	0.00991	0.0248	CbGeAlD
Miglustat—UGCG—lymph node—uterine cancer	0.00977	0.0244	CbGeAlD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.00467	0.0607	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.00427	0.0555	CbGpPWpGaD
Miglustat—Pain in extremity—Progesterone—uterine cancer	0.00371	0.0071	CcSEcCtD
Miglustat—Disturbance in sexual arousal—Progesterone—uterine cancer	0.00368	0.00704	CcSEcCtD
Miglustat—Migraine—Progesterone—uterine cancer	0.00365	0.00698	CcSEcCtD
Miglustat—Libido decreased—Medroxyprogesterone Acetate—uterine cancer	0.00362	0.00693	CcSEcCtD
Miglustat—Amnesia—Medroxyprogesterone Acetate—uterine cancer	0.00358	0.00684	CcSEcCtD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—PIK3CA—uterine cancer	0.00357	0.0464	CbGpPWpGaD
Miglustat—Visual disturbance—Medroxyprogesterone Acetate—uterine cancer	0.00355	0.00678	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00338	0.0439	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00338	0.0439	CbGpPWpGaD
Miglustat—Pain in extremity—Medroxyprogesterone Acetate—uterine cancer	0.00336	0.00643	CcSEcCtD
Miglustat—Cramp muscle—Progesterone—uterine cancer	0.00334	0.00639	CcSEcCtD
Miglustat—Disturbance in sexual arousal—Medroxyprogesterone Acetate—uterine cancer	0.00333	0.00638	CcSEcCtD
Miglustat—Migraine—Medroxyprogesterone Acetate—uterine cancer	0.00331	0.00633	CcSEcCtD
Miglustat—Tingling sensation—Etoposide—uterine cancer	0.00325	0.00622	CcSEcCtD
Miglustat—Abdominal distension—Progesterone—uterine cancer	0.00323	0.00617	CcSEcCtD
Miglustat—Ataxia—Medroxyprogesterone Acetate—uterine cancer	0.00316	0.00605	CcSEcCtD
Miglustat—Numbness—Etoposide—uterine cancer	0.00315	0.00603	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00309	0.0401	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00309	0.0401	CbGpPWpGaD
Miglustat—Cramp muscle—Medroxyprogesterone Acetate—uterine cancer	0.00303	0.00579	CcSEcCtD
Miglustat—Sensory loss—Etoposide—uterine cancer	0.00302	0.00577	CcSEcCtD
Miglustat—Pain—Carboplatin—uterine cancer	0.00297	0.00568	CcSEcCtD
Miglustat—Muscular weakness—Medroxyprogesterone Acetate—uterine cancer	0.00296	0.00567	CcSEcCtD
Miglustat—Abdominal distension—Medroxyprogesterone Acetate—uterine cancer	0.00292	0.00559	CcSEcCtD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—AKT1—uterine cancer	0.00292	0.0379	CbGpPWpGaD
Miglustat—Weight decreased—Progesterone—uterine cancer	0.0029	0.00555	CcSEcCtD
Miglustat—Depression—Progesterone—uterine cancer	0.00285	0.00545	CcSEcCtD
Miglustat—Neuropathy peripheral—Progesterone—uterine cancer	0.0028	0.00536	CcSEcCtD
Miglustat—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.00263	0.00503	CcSEcCtD
Miglustat—Depression—Medroxyprogesterone Acetate—uterine cancer	0.00258	0.00494	CcSEcCtD
Miglustat—Haemoglobin—Progesterone—uterine cancer	0.00258	0.00493	CcSEcCtD
Miglustat—Haemorrhage—Progesterone—uterine cancer	0.00257	0.00491	CcSEcCtD
Miglustat—Neuropathy peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00254	0.00486	CcSEcCtD
Miglustat—Connective tissue disorder—Progesterone—uterine cancer	0.00252	0.00482	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.00248	0.0322	CbGpPWpGaD
Miglustat—Visual impairment—Progesterone—uterine cancer	0.00247	0.00473	CcSEcCtD
Miglustat—Neuropathy—Etoposide—uterine cancer	0.00245	0.00469	CcSEcCtD
Miglustat—Eye disorder—Progesterone—uterine cancer	0.0024	0.00459	CcSEcCtD
Miglustat—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.00234	0.00447	CcSEcCtD
Miglustat—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00232	0.00445	CcSEcCtD
Miglustat—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.00228	0.00437	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.00227	0.0294	CbGpPWpGaD
Miglustat—Mental disorder—Progesterone—uterine cancer	0.00225	0.0043	CcSEcCtD
Miglustat—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.00224	0.00429	CcSEcCtD
Miglustat—Malnutrition—Progesterone—uterine cancer	0.00223	0.00427	CcSEcCtD
Miglustat—Flatulence—Progesterone—uterine cancer	0.0022	0.00421	CcSEcCtD
Miglustat—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.00217	0.00416	CcSEcCtD
Miglustat—Nervousness—Progesterone—uterine cancer	0.00217	0.00415	CcSEcCtD
Miglustat—Back pain—Progesterone—uterine cancer	0.00216	0.00413	CcSEcCtD
Miglustat—Muscle spasms—Progesterone—uterine cancer	0.00215	0.00411	CcSEcCtD
Miglustat—Tremor—Progesterone—uterine cancer	0.00209	0.004	CcSEcCtD
Miglustat—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00209	0.00399	CcSEcCtD
Miglustat—GBA2—Metabolism—NDUFB11—uterine cancer	0.00208	0.027	CbGpPWpGaD
Miglustat—GBA2—Metabolism—SRD5A2—uterine cancer	0.00208	0.027	CbGpPWpGaD
Miglustat—Ill-defined disorder—Progesterone—uterine cancer	0.00207	0.00396	CcSEcCtD
Miglustat—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00204	0.0039	CcSEcCtD
Miglustat—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00202	0.00387	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.00202	0.0262	CbGpPWpGaD
Miglustat—Malaise—Progesterone—uterine cancer	0.00201	0.00385	CcSEcCtD
Miglustat—Vertigo—Progesterone—uterine cancer	0.00201	0.00384	CcSEcCtD
Miglustat—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00199	0.00382	CcSEcCtD
Miglustat—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.00197	0.00376	CcSEcCtD
Miglustat—Neuritis—Epirubicin—uterine cancer	0.00196	0.00375	CcSEcCtD
Miglustat—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00196	0.00375	CcSEcCtD
Miglustat—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00195	0.00372	CcSEcCtD
Miglustat—Convulsion—Progesterone—uterine cancer	0.00193	0.0037	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.00191	0.0248	CbGpPWpGaD
Miglustat—UGCG—Metabolism—SRD5A2—uterine cancer	0.0019	0.0247	CbGpPWpGaD
Miglustat—UGCG—Metabolism—NDUFB11—uterine cancer	0.0019	0.0247	CbGpPWpGaD
Miglustat—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.0019	0.00363	CcSEcCtD
Miglustat—Discomfort—Progesterone—uterine cancer	0.00188	0.00359	CcSEcCtD
Miglustat—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00188	0.00359	CcSEcCtD
Miglustat—Dry mouth—Progesterone—uterine cancer	0.00186	0.00356	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.00185	0.024	CbGpPWpGaD
Miglustat—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00182	0.00349	CcSEcCtD
Miglustat—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00182	0.00348	CcSEcCtD
Miglustat—Neuritis—Doxorubicin—uterine cancer	0.00182	0.00347	CcSEcCtD
Miglustat—Nervous system disorder—Progesterone—uterine cancer	0.00179	0.00342	CcSEcCtD
Miglustat—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00175	0.00335	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.00174	0.0227	CbGpPWpGaD
Miglustat—Anorexia—Progesterone—uterine cancer	0.00174	0.00332	CcSEcCtD
Miglustat—Cramp muscle—Etoposide—uterine cancer	0.00171	0.00327	CcSEcCtD
Miglustat—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.0017	0.00326	CcSEcCtD
Miglustat—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00168	0.00322	CcSEcCtD
Miglustat—Insomnia—Progesterone—uterine cancer	0.00165	0.00315	CcSEcCtD
Miglustat—Paraesthesia—Progesterone—uterine cancer	0.00164	0.00313	CcSEcCtD
Miglustat—Chills—Dactinomycin—uterine cancer	0.00163	0.00311	CcSEcCtD
Miglustat—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00162	0.0031	CcSEcCtD
Miglustat—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00162	0.00309	CcSEcCtD
Miglustat—Dyspepsia—Progesterone—uterine cancer	0.0016	0.00307	CcSEcCtD
Miglustat—Decreased appetite—Progesterone—uterine cancer	0.00158	0.00303	CcSEcCtD
Miglustat—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00157	0.00301	CcSEcCtD
Miglustat—Gastrointestinal disorder—Progesterone—uterine cancer	0.00157	0.00301	CcSEcCtD
Miglustat—Fatigue—Progesterone—uterine cancer	0.00157	0.00301	CcSEcCtD
Miglustat—Constipation—Progesterone—uterine cancer	0.00156	0.00298	CcSEcCtD
Miglustat—Pain—Progesterone—uterine cancer	0.00156	0.00298	CcSEcCtD
Miglustat—GBA2—Metabolism—STAR—uterine cancer	0.0015	0.0195	CbGpPWpGaD
Miglustat—GBA2—Metabolism—AKR1B1—uterine cancer	0.0015	0.0195	CbGpPWpGaD
Miglustat—Feeling abnormal—Progesterone—uterine cancer	0.0015	0.00287	CcSEcCtD
Miglustat—Gait disturbance—Epirubicin—uterine cancer	0.0015	0.00287	CcSEcCtD
Miglustat—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00149	0.00286	CcSEcCtD
Miglustat—Gastrointestinal pain—Progesterone—uterine cancer	0.00149	0.00285	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.00149	0.0193	CbGpPWpGaD
Miglustat—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00284	CcSEcCtD
Miglustat—Ill-defined disorder—Dactinomycin—uterine cancer	0.00146	0.0028	CcSEcCtD
Miglustat—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.00278	CcSEcCtD
Miglustat—Abdominal pain—Progesterone—uterine cancer	0.00144	0.00276	CcSEcCtD
Miglustat—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.00275	CcSEcCtD
Miglustat—Neuropathy peripheral—Etoposide—uterine cancer	0.00143	0.00274	CcSEcCtD
Miglustat—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00143	0.00273	CcSEcCtD
Miglustat—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00272	CcSEcCtD
Miglustat—Malaise—Dactinomycin—uterine cancer	0.00142	0.00272	CcSEcCtD
Miglustat—Influenza like illness—Epirubicin—uterine cancer	0.00142	0.00272	CcSEcCtD
Miglustat—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.0027	CcSEcCtD
Miglustat—Gait disturbance—Doxorubicin—uterine cancer	0.00139	0.00266	CcSEcCtD
Miglustat—Neuropathy—Epirubicin—uterine cancer	0.00138	0.00263	CcSEcCtD
Miglustat—UGCG—Metabolism—STAR—uterine cancer	0.00138	0.0179	CbGpPWpGaD
Miglustat—UGCG—Metabolism—AKR1B1—uterine cancer	0.00138	0.0179	CbGpPWpGaD
Miglustat—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.0026	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.00136	0.0177	CbGpPWpGaD
Miglustat—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00258	CcSEcCtD
Miglustat—Cramps of lower extremities—Epirubicin—uterine cancer	0.00135	0.00257	CcSEcCtD
Miglustat—Discomfort—Dactinomycin—uterine cancer	0.00133	0.00254	CcSEcCtD
Miglustat—Influenza like illness—Doxorubicin—uterine cancer	0.00132	0.00252	CcSEcCtD
Miglustat—Asthenia—Progesterone—uterine cancer	0.00131	0.0025	CcSEcCtD
Miglustat—Hypoaesthesia—Etoposide—uterine cancer	0.00131	0.0025	CcSEcCtD
Miglustat—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.0025	CcSEcCtD
Miglustat—Neuropathy—Doxorubicin—uterine cancer	0.00127	0.00243	CcSEcCtD
Miglustat—Thrombocytopenia—Dactinomycin—uterine cancer	0.00126	0.00241	CcSEcCtD
Miglustat—Diarrhoea—Progesterone—uterine cancer	0.00125	0.00239	CcSEcCtD
Miglustat—Cramps of lower extremities—Doxorubicin—uterine cancer	0.00125	0.00238	CcSEcCtD
Miglustat—Anorexia—Dactinomycin—uterine cancer	0.00123	0.00235	CcSEcCtD
Miglustat—Eye disorder—Etoposide—uterine cancer	0.00123	0.00235	CcSEcCtD
Miglustat—Dizziness—Progesterone—uterine cancer	0.00121	0.00231	CcSEcCtD
Miglustat—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00227	CcSEcCtD
Miglustat—GBA2—Metabolism—POLD1—uterine cancer	0.00118	0.0153	CbGpPWpGaD
Miglustat—Chills—Etoposide—uterine cancer	0.00118	0.00225	CcSEcCtD
Miglustat—Vomiting—Progesterone—uterine cancer	0.00116	0.00222	CcSEcCtD
Miglustat—Headache—Progesterone—uterine cancer	0.00114	0.00218	CcSEcCtD
Miglustat—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.00216	CcSEcCtD
Miglustat—Decreased appetite—Dactinomycin—uterine cancer	0.00112	0.00214	CcSEcCtD
Miglustat—Fatigue—Dactinomycin—uterine cancer	0.00111	0.00212	CcSEcCtD
Miglustat—Back pain—Etoposide—uterine cancer	0.0011	0.00211	CcSEcCtD
Miglustat—GBA2—Metabolism—AKR1C1—uterine cancer	0.0011	0.0143	CbGpPWpGaD
Miglustat—Pain—Dactinomycin—uterine cancer	0.0011	0.00211	CcSEcCtD
Miglustat—Muscle spasms—Etoposide—uterine cancer	0.0011	0.0021	CcSEcCtD
Miglustat—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00209	CcSEcCtD
Miglustat—Nausea—Progesterone—uterine cancer	0.00108	0.00207	CcSEcCtD
Miglustat—UGCG—Metabolism—POLD1—uterine cancer	0.00108	0.014	CbGpPWpGaD
Miglustat—Pain in extremity—Epirubicin—uterine cancer	0.00106	0.00203	CcSEcCtD
Miglustat—Feeling abnormal—Dactinomycin—uterine cancer	0.00106	0.00203	CcSEcCtD
Miglustat—Ill-defined disorder—Etoposide—uterine cancer	0.00106	0.00203	CcSEcCtD
Miglustat—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00105	0.00202	CcSEcCtD
Miglustat—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.00201	CcSEcCtD
Miglustat—Migraine—Epirubicin—uterine cancer	0.00105	0.002	CcSEcCtD
Miglustat—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00198	CcSEcCtD
Miglustat—Malaise—Etoposide—uterine cancer	0.00103	0.00197	CcSEcCtD
Miglustat—Vertigo—Etoposide—uterine cancer	0.00103	0.00196	CcSEcCtD
Miglustat—Abdominal pain—Dactinomycin—uterine cancer	0.00102	0.00195	CcSEcCtD
Miglustat—UGCG—Metabolism—AKR1C1—uterine cancer	0.00101	0.0131	CbGpPWpGaD
Miglustat—Ataxia—Epirubicin—uterine cancer	0.001	0.00191	CcSEcCtD
Miglustat—Convulsion—Etoposide—uterine cancer	0.00099	0.00189	CcSEcCtD
Miglustat—Pain in extremity—Doxorubicin—uterine cancer	0.000984	0.00188	CcSEcCtD
Miglustat—GBA2—Metabolism—RRM2—uterine cancer	0.000984	0.0128	CbGpPWpGaD
Miglustat—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000981	0.00188	CcSEcCtD
Miglustat—Abdominal pain upper—Epirubicin—uterine cancer	0.000971	0.00186	CcSEcCtD
Miglustat—Migraine—Doxorubicin—uterine cancer	0.000968	0.00185	CcSEcCtD
Miglustat—Discomfort—Etoposide—uterine cancer	0.000961	0.00184	CcSEcCtD
Miglustat—GBA2—Metabolism—DCN—uterine cancer	0.000955	0.0124	CbGpPWpGaD
Miglustat—Muscular weakness—Epirubicin—uterine cancer	0.000938	0.00179	CcSEcCtD
Miglustat—Abdominal distension—Epirubicin—uterine cancer	0.000925	0.00177	CcSEcCtD
Miglustat—Ataxia—Doxorubicin—uterine cancer	0.000925	0.00177	CcSEcCtD
Miglustat—Asthenia—Dactinomycin—uterine cancer	0.000924	0.00177	CcSEcCtD
Miglustat—Thrombocytopenia—Etoposide—uterine cancer	0.000913	0.00175	CcSEcCtD
Miglustat—UGCG—Metabolism—RRM2—uterine cancer	0.0009	0.0117	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CYP11A1—uterine cancer	0.0009	0.0117	CbGpPWpGaD
Miglustat—Abdominal pain upper—Doxorubicin—uterine cancer	0.000899	0.00172	CcSEcCtD
Miglustat—Anorexia—Etoposide—uterine cancer	0.000889	0.0017	CcSEcCtD
Miglustat—Diarrhoea—Dactinomycin—uterine cancer	0.000881	0.00169	CcSEcCtD
Miglustat—UGCG—Metabolism—DCN—uterine cancer	0.000873	0.0113	CbGpPWpGaD
Miglustat—Muscular weakness—Doxorubicin—uterine cancer	0.000868	0.00166	CcSEcCtD
Miglustat—Abdominal distension—Doxorubicin—uterine cancer	0.000856	0.00164	CcSEcCtD
Miglustat—GBA2—Metabolism—AKR1C3—uterine cancer	0.00085	0.011	CbGpPWpGaD
Miglustat—Paraesthesia—Etoposide—uterine cancer	0.000837	0.0016	CcSEcCtD
Miglustat—Weight decreased—Epirubicin—uterine cancer	0.000831	0.00159	CcSEcCtD
Miglustat—UGCG—Metabolism—CYP11A1—uterine cancer	0.000823	0.0107	CbGpPWpGaD
Miglustat—Vomiting—Dactinomycin—uterine cancer	0.000819	0.00157	CcSEcCtD
Miglustat—Decreased appetite—Etoposide—uterine cancer	0.00081	0.00155	CcSEcCtD
Miglustat—Gastrointestinal disorder—Etoposide—uterine cancer	0.000805	0.00154	CcSEcCtD
Miglustat—Fatigue—Etoposide—uterine cancer	0.000804	0.00154	CcSEcCtD
Miglustat—Neuropathy peripheral—Epirubicin—uterine cancer	0.000803	0.00154	CcSEcCtD
Miglustat—Constipation—Etoposide—uterine cancer	0.000797	0.00153	CcSEcCtD
Miglustat—Pain—Etoposide—uterine cancer	0.000797	0.00153	CcSEcCtD
Miglustat—UGCG—Metabolism—AKR1C3—uterine cancer	0.000777	0.0101	CbGpPWpGaD
Miglustat—Weight decreased—Doxorubicin—uterine cancer	0.000769	0.00147	CcSEcCtD
Miglustat—Feeling abnormal—Etoposide—uterine cancer	0.000768	0.00147	CcSEcCtD
Miglustat—Nausea—Dactinomycin—uterine cancer	0.000765	0.00146	CcSEcCtD
Miglustat—Gastrointestinal pain—Etoposide—uterine cancer	0.000762	0.00146	CcSEcCtD
Miglustat—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000743	0.00142	CcSEcCtD
Miglustat—Haemoglobin—Epirubicin—uterine cancer	0.000739	0.00141	CcSEcCtD
Miglustat—Abdominal pain—Etoposide—uterine cancer	0.000737	0.00141	CcSEcCtD
Miglustat—Haemorrhage—Epirubicin—uterine cancer	0.000736	0.00141	CcSEcCtD
Miglustat—Hypoaesthesia—Epirubicin—uterine cancer	0.000732	0.0014	CcSEcCtD
Miglustat—Connective tissue disorder—Epirubicin—uterine cancer	0.000723	0.00138	CcSEcCtD
Miglustat—Visual impairment—Epirubicin—uterine cancer	0.000709	0.00136	CcSEcCtD
Miglustat—Eye disorder—Epirubicin—uterine cancer	0.000687	0.00132	CcSEcCtD
Miglustat—Haemoglobin—Doxorubicin—uterine cancer	0.000684	0.00131	CcSEcCtD
Miglustat—Haemorrhage—Doxorubicin—uterine cancer	0.000681	0.0013	CcSEcCtD
Miglustat—Hypoaesthesia—Doxorubicin—uterine cancer	0.000677	0.0013	CcSEcCtD
Miglustat—Asthenia—Etoposide—uterine cancer	0.000669	0.00128	CcSEcCtD
Miglustat—Connective tissue disorder—Doxorubicin—uterine cancer	0.000669	0.00128	CcSEcCtD
Miglustat—GBA2—Metabolism—CYP19A1—uterine cancer	0.000662	0.0086	CbGpPWpGaD
Miglustat—GBA2—Metabolism—STK11—uterine cancer	0.000662	0.0086	CbGpPWpGaD
Miglustat—Chills—Epirubicin—uterine cancer	0.00066	0.00126	CcSEcCtD
Miglustat—Visual impairment—Doxorubicin—uterine cancer	0.000656	0.00126	CcSEcCtD
Miglustat—Mental disorder—Epirubicin—uterine cancer	0.000644	0.00123	CcSEcCtD
Miglustat—Malnutrition—Epirubicin—uterine cancer	0.00064	0.00123	CcSEcCtD
Miglustat—Diarrhoea—Etoposide—uterine cancer	0.000638	0.00122	CcSEcCtD
Miglustat—Eye disorder—Doxorubicin—uterine cancer	0.000636	0.00122	CcSEcCtD
Miglustat—Flatulence—Epirubicin—uterine cancer	0.000631	0.00121	CcSEcCtD
Miglustat—Nervousness—Epirubicin—uterine cancer	0.000622	0.00119	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000621	0.00807	CbGpPWpGaD
Miglustat—Back pain—Epirubicin—uterine cancer	0.000619	0.00119	CcSEcCtD
Miglustat—Dizziness—Etoposide—uterine cancer	0.000617	0.00118	CcSEcCtD
Miglustat—Muscle spasms—Epirubicin—uterine cancer	0.000616	0.00118	CcSEcCtD
Miglustat—Chills—Doxorubicin—uterine cancer	0.000611	0.00117	CcSEcCtD
Miglustat—UGCG—Metabolism—STK11—uterine cancer	0.000605	0.00786	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CYP19A1—uterine cancer	0.000605	0.00786	CbGpPWpGaD
Miglustat—Mental disorder—Doxorubicin—uterine cancer	0.000596	0.00114	CcSEcCtD
Miglustat—Ill-defined disorder—Epirubicin—uterine cancer	0.000594	0.00114	CcSEcCtD
Miglustat—Vomiting—Etoposide—uterine cancer	0.000593	0.00113	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000593	0.0077	CbGpPWpGaD
Miglustat—Malnutrition—Doxorubicin—uterine cancer	0.000592	0.00113	CcSEcCtD
Miglustat—Headache—Etoposide—uterine cancer	0.000584	0.00112	CcSEcCtD
Miglustat—Flatulence—Doxorubicin—uterine cancer	0.000584	0.00112	CcSEcCtD
Miglustat—Malaise—Epirubicin—uterine cancer	0.000577	0.0011	CcSEcCtD
Miglustat—Nervousness—Doxorubicin—uterine cancer	0.000575	0.0011	CcSEcCtD
Miglustat—Vertigo—Epirubicin—uterine cancer	0.000575	0.0011	CcSEcCtD
Miglustat—Back pain—Doxorubicin—uterine cancer	0.000573	0.0011	CcSEcCtD
Miglustat—Muscle spasms—Doxorubicin—uterine cancer	0.00057	0.00109	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000568	0.00738	CbGpPWpGaD
Miglustat—Convulsion—Epirubicin—uterine cancer	0.000555	0.00106	CcSEcCtD
Miglustat—Nausea—Etoposide—uterine cancer	0.000554	0.00106	CcSEcCtD
Miglustat—Ill-defined disorder—Doxorubicin—uterine cancer	0.00055	0.00105	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000542	0.00704	CbGpPWpGaD
Miglustat—Discomfort—Epirubicin—uterine cancer	0.000539	0.00103	CcSEcCtD
Miglustat—Malaise—Doxorubicin—uterine cancer	0.000534	0.00102	CcSEcCtD
Miglustat—Dry mouth—Epirubicin—uterine cancer	0.000533	0.00102	CcSEcCtD
Miglustat—Vertigo—Doxorubicin—uterine cancer	0.000532	0.00102	CcSEcCtD
Miglustat—Convulsion—Doxorubicin—uterine cancer	0.000513	0.000982	CcSEcCtD
Miglustat—Nervous system disorder—Epirubicin—uterine cancer	0.000512	0.000981	CcSEcCtD
Miglustat—Thrombocytopenia—Epirubicin—uterine cancer	0.000512	0.000979	CcSEcCtD
Miglustat—Discomfort—Doxorubicin—uterine cancer	0.000498	0.000954	CcSEcCtD
Miglustat—Anorexia—Epirubicin—uterine cancer	0.000498	0.000953	CcSEcCtD
Miglustat—GBA2—Metabolism—MTHFR—uterine cancer	0.000497	0.00646	CbGpPWpGaD
Miglustat—Dry mouth—Doxorubicin—uterine cancer	0.000493	0.000944	CcSEcCtD
Miglustat—Nervous system disorder—Doxorubicin—uterine cancer	0.000474	0.000907	CcSEcCtD
Miglustat—Thrombocytopenia—Doxorubicin—uterine cancer	0.000473	0.000906	CcSEcCtD
Miglustat—Insomnia—Epirubicin—uterine cancer	0.000473	0.000904	CcSEcCtD
Miglustat—Paraesthesia—Epirubicin—uterine cancer	0.000469	0.000898	CcSEcCtD
Miglustat—Anorexia—Doxorubicin—uterine cancer	0.000461	0.000882	CcSEcCtD
Miglustat—Dyspepsia—Epirubicin—uterine cancer	0.00046	0.00088	CcSEcCtD
Miglustat—UGCG—Metabolism—MTHFR—uterine cancer	0.000455	0.00591	CbGpPWpGaD
Miglustat—Decreased appetite—Epirubicin—uterine cancer	0.000454	0.000869	CcSEcCtD
Miglustat—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000451	0.000863	CcSEcCtD
Miglustat—Fatigue—Epirubicin—uterine cancer	0.000451	0.000862	CcSEcCtD
Miglustat—Constipation—Epirubicin—uterine cancer	0.000447	0.000855	CcSEcCtD
Miglustat—Pain—Epirubicin—uterine cancer	0.000447	0.000855	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000438	0.00569	CbGpPWpGaD
Miglustat—Insomnia—Doxorubicin—uterine cancer	0.000437	0.000837	CcSEcCtD
Miglustat—Paraesthesia—Doxorubicin—uterine cancer	0.000434	0.000831	CcSEcCtD
Miglustat—Feeling abnormal—Epirubicin—uterine cancer	0.000431	0.000824	CcSEcCtD
Miglustat—Gastrointestinal pain—Epirubicin—uterine cancer	0.000427	0.000818	CcSEcCtD
Miglustat—Dyspepsia—Doxorubicin—uterine cancer	0.000426	0.000814	CcSEcCtD
Miglustat—Decreased appetite—Doxorubicin—uterine cancer	0.00042	0.000804	CcSEcCtD
Miglustat—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000417	0.000799	CcSEcCtD
Miglustat—Fatigue—Doxorubicin—uterine cancer	0.000417	0.000798	CcSEcCtD
Miglustat—Constipation—Doxorubicin—uterine cancer	0.000414	0.000791	CcSEcCtD
Miglustat—Pain—Doxorubicin—uterine cancer	0.000414	0.000791	CcSEcCtD
Miglustat—Abdominal pain—Epirubicin—uterine cancer	0.000413	0.00079	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000401	0.00521	CbGpPWpGaD
Miglustat—Feeling abnormal—Doxorubicin—uterine cancer	0.000398	0.000762	CcSEcCtD
Miglustat—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000395	0.000757	CcSEcCtD
Miglustat—Abdominal pain—Doxorubicin—uterine cancer	0.000382	0.000731	CcSEcCtD
Miglustat—Asthenia—Epirubicin—uterine cancer	0.000375	0.000717	CcSEcCtD
Miglustat—Diarrhoea—Epirubicin—uterine cancer	0.000358	0.000684	CcSEcCtD
Miglustat—Asthenia—Doxorubicin—uterine cancer	0.000347	0.000664	CcSEcCtD
Miglustat—Dizziness—Epirubicin—uterine cancer	0.000346	0.000661	CcSEcCtD
Miglustat—Vomiting—Epirubicin—uterine cancer	0.000332	0.000636	CcSEcCtD
Miglustat—Diarrhoea—Doxorubicin—uterine cancer	0.000331	0.000633	CcSEcCtD
Miglustat—Headache—Epirubicin—uterine cancer	0.000327	0.000626	CcSEcCtD
Miglustat—Dizziness—Doxorubicin—uterine cancer	0.00032	0.000612	CcSEcCtD
Miglustat—Nausea—Epirubicin—uterine cancer	0.00031	0.000594	CcSEcCtD
Miglustat—Vomiting—Doxorubicin—uterine cancer	0.000307	0.000588	CcSEcCtD
Miglustat—Headache—Doxorubicin—uterine cancer	0.000303	0.00058	CcSEcCtD
Miglustat—Nausea—Doxorubicin—uterine cancer	0.000287	0.00055	CcSEcCtD
Miglustat—GBA2—Metabolism—PTEN—uterine cancer	0.000277	0.00359	CbGpPWpGaD
Miglustat—GBA2—Metabolism—EP300—uterine cancer	0.000264	0.00343	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PTEN—uterine cancer	0.000253	0.00329	CbGpPWpGaD
Miglustat—UGCG—Metabolism—EP300—uterine cancer	0.000241	0.00313	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PIK3CA—uterine cancer	0.000195	0.00254	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PIK3CA—uterine cancer	0.000179	0.00232	CbGpPWpGaD
Miglustat—GBA2—Metabolism—AKT1—uterine cancer	0.000159	0.00207	CbGpPWpGaD
Miglustat—UGCG—Metabolism—AKT1—uterine cancer	0.000146	0.00189	CbGpPWpGaD
